Sunbio Overview
- Year Founded
-
1997
- Status
-
Public
- Employees
-
23
- Stock Symbol
-
067370
- Share Price
-
$5.00
- (As of Friday Closing)
Sunbio General Information
Description
SunBio Inc is a biotechnology company. The Company develops biosimilars, biopharmaceuticals, and medical devices based on its proprietary technologies of pegylation.
Contact Information
Website
www.sunbio.comCorporate Office
- 95 Sanbon-ro
- Gunpo-si, 15849
- South Korea
Corporate Office
- 95 Sanbon-ro
- Gunpo-si, 15849
- South Korea
Sunbio Stock Performance
As of 11-Jul-2025, Sunbio’s stock price is $5.00. Its current market cap is $62M with 12.3M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.00 | $5.04 | $3.99 - $7.17 | $62M | 12.3M | 31.7K | $0.05 |
Sunbio Financials Summary
As of 31-Mar-2025, Sunbio has a trailing 12-month revenue of $7.04M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 71,270 | 74,386 | 117,181 | 114,753 |
| Revenue | 7,041 | 6,364 | 9,401 | 5,743 |
| EBITDA | 2,110 | 1,146 | 4,783 | 1,359 |
| Net Income | 635 | (77) | 3,523 | 673 |
| Total Assets | 41,589 | 41,425 | 36,986 | 33,968 |
| Total Debt | 20,552 | 20,531 | 12,788 | 14,337 |
Sunbio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sunbio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sunbio Patents
Sunbio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240269349-A1 | Sol-gel conversion over time of 6-arm peg hydrogel | Pending | 09-Sep-2021 | ||
| JP-2024531616-A | Sol-gel transformation of 6-arm peg hydrate gel over time | Pending | 09-Sep-2021 | ||
| EP-4400125-A1 | Sol-gel transition of 6-arm peg hydrogel over time | Pending | 09-Sep-2021 | ||
| EP-4331566-A1 | Mouth rinse composition including polyethylene glycol derivative as active ingredient for alleviating xerostomia | Pending | 22-Mar-2021 | ||
| EP-4331566-A4 | Mouth rinse composition including polyethylene glycol derivative as active ingredient for alleviating xerostomia | Pending | 22-Mar-2021 | A61K31/787 |
Sunbio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sunbio FAQs
-
When was Sunbio founded?
Sunbio was founded in 1997.
-
Where is Sunbio headquartered?
Sunbio is headquartered in Gunpo-si, South Korea.
-
What is the size of Sunbio?
Sunbio has 23 total employees.
-
What industry is Sunbio in?
Sunbio’s primary industry is Drug Discovery.
-
Is Sunbio a private or public company?
Sunbio is a Public company.
-
What is Sunbio’s stock symbol?
The ticker symbol for Sunbio is 067370.
-
What is the current stock price of Sunbio?
As of 11-Jul-2025 the stock price of Sunbio is $5.00.
-
What is the current market cap of Sunbio?
The current market capitalization of Sunbio is $62M.
-
What is Sunbio’s current revenue?
The trailing twelve month revenue for Sunbio is $7.04M.
-
What is Sunbio’s annual earnings per share (EPS)?
Sunbio’s EPS for 12 months was $0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
